<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Pharmaceutical Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02257/Pharmaceutical.html</link>
    <description><![CDATA[Reportlinker.com Lastest Pharmaceutical Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Tue, 21 May 2013 14:03:36 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Company Report: Therapeutics in The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014318890/Company-Report-Therapeutics-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014318890/Company-Report-Therapeutics-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... On applying gene  <strong>therapy</strong> technology to genetically modify a patient S  own t-cells, known as chimeric antigen receptor (car)  t-cells, to target and destroy cancer cells. Celgene has  an option to license any ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Pathology in The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014321753/Company-Report-Pathology-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014321753/Company-Report-Pathology-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Pathology in The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014318650/Company-Report-Pathology-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014318650/Company-Report-Pathology-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Stribild gilead hiv-1 infection aug. 27 Neutroval sicor biotech neutropenia aug. 29 Linzess forest ibs aug. 30 Xtandi astellas prostate cancer aug. 31 Bosulif pfizer leukemia sep. 4 Aubagio sanofi <strong>multiple</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Prescription Drug Production and Trade Statistics in The United States]]></title>
      <link>http://www.reportlinker.com/d014338285/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014338285/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Vitamin D Sector Analysis]]></title>
      <link>http://www.reportlinker.com/d014330072/U-S-Vitamin-D-Sector-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014330072/U-S-Vitamin-D-Sector-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... We know patients are deficient in it, so important to  treat it anyway. Also why not have nonunion patients  take a product that has:   Calcium (dairy)   <Strong>vitamin</strong> <strong>k</strong>2 (natto, fermented cheese and organ ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccine Market in Tanzania]]></title>
      <link>http://www.reportlinker.com/d014338643/Vaccine-Market-in-Tanzania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014338643/Vaccine-Market-in-Tanzania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of a <strong>polio</strong> <strong>vaccine</strong> what does it take to vaccinate a child against polio  This two-minute video from unicef shows us that  the journey of a <strong>polio</strong> <strong>vaccine</strong> is an incredibly complex process. The menafrivac ctc ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Industry Analysis  in The United States and Canada]]></title>
      <link>http://www.reportlinker.com/d014323762/Drug-Industry-Analysis-in-The-United-States-and-Canada.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014323762/Drug-Industry-Analysis-in-The-United-States-and-Canada.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... To production interruptions and  diminished capacity    Economic choices are made where older,  less profitable <strong>drugs</strong> are eliminated as new  generics come to market   By year-end 2012, we will see $34b in new ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Swazi Pharmaceutical Industry]]></title>
      <link>http://www.reportlinker.com/d014304357/The-Swazi-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014304357/The-Swazi-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Production v livestock production v natural resources vdiscuss the roles of government on hiv/<strong>aids</strong> vdiscuss the roles of pepfar u.S government  organization on hiv/<strong>aids</strong> vdiscuss the impact of hiv/<strong>aids</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Sector in Malaysia]]></title>
      <link>http://www.reportlinker.com/d014321956/Drug-and-Medication-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014321956/Drug-and-Medication-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Adulterants were found to be therapeutic substances  associated with the specific indications of the products such as  adulterant for sexual enhancement <strong>drugs</strong> ( sildenafil, tadalafil ), pain  relieving <strong>drugs</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Industry]]></title>
      <link>http://www.reportlinker.com/d014318697/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014318697/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Sorbentstm  competition  38  no approved therapies in the eu or us to prevent or treat organ failure       Sepsis     Ards and ali     Burn injury     Trauma     Severe <strong>acute</strong> <strong>pancreatitis</strong>     Cardiopulmonary bypass ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Europe Pharmaceutical & Healthcare Reports  ]]></title>
      <link>http://www.reportlinker.com/p01105886/Europe-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01105886/Europe-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1437.gif"> Key Benefits   ?  Benchmark independent pharmaceutical and healthcare industry forecasts to test other views - a key input for successful budgeting and strategic business planning in the pharmaceutical ...]]></description>
      <pubDate>Wed, 20 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - Global Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181924/Vaccines-Global-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181924/Vaccines-Global-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Middle East & Africa Pharmaceutical & Healthcare Reports]]></title>
      <link>http://www.reportlinker.com/p01117725/The-Middle-East-Africa-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01117725/The-Middle-East-Africa-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Espicom market intelligence, brought to you by Business Monitor International The Middle East & Africa Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Asian Pharmaceuticals and Healthcare Reports]]></title>
      <link>http://www.reportlinker.com/p01117723/Asian-Pharmaceuticals-and-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01117723/Asian-Pharmaceuticals-and-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Espicom market intelligence, brought to you by Business Monitor International WHY THESE REPORTS ARE IMPORTANT Despite on-going economic pressures, the pharmaceutical industry is one of the most successful ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - European Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181922/Vaccines-Western-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181922/Vaccines-Western-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Insulin Glargine  - Comprehensive patent search]]></title>
      <link>http://www.reportlinker.com/p01100214/Insulin-Glargine-Comprehensive-patent-search.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01100214/Insulin-Glargine-Comprehensive-patent-search.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1529.gif">  Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Insulin Aspart  - Comprehensive patent search]]></title>
      <link>http://www.reportlinker.com/p01158094/Insulin-Aspart-Comprehensive-patent-search.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01158094/Insulin-Aspart-Comprehensive-patent-search.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1529.gif"> Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
